专题：Lymphoma Diagnosis and Treatment

This cluster of papers focuses on the classification, molecular profiling, genetic pathogenesis, and treatment strategies for various types of lymphoid neoplasms, including Hodgkin's lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and peripheral T-cell lymphoma. It also explores the use of PET imaging, rituximab therapy, and gene expression profiling to predict survival and guide treatment decisions.
最新文献
EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation

article Full Text OpenAlex

Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18–65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network

article Full Text OpenAlex

Lisocabtagene maraleucel in patients with relapsed or refractory marginal zone lymphoma (TRANSCEND FL): primary analysis results from the global, multicohort, single-arm, phase 2 study

article Full Text OpenAlex

Disease burden of hematological malignancies worldwide, in China and in the United States based on the GLOBOCAN 2022 and Global Burden of Disease 2021 data

article Full Text OpenAlex

American Society of Hematology 2026 guidelines for frontline management of acute lymphoblastic leukemia in adolescents and young adults

article Full Text OpenAlex

Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology

article Full Text OpenAlex

2026 Update on the Management of Diffuse Large B‐Cell Lymphoma

article Full Text OpenAlex

The landscape and evolution of clonal hematopoiesis in chronic lymphocytic leukemia

article Full Text OpenAlex

A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma

article Full Text OpenAlex

First-line treatment for CLL in the era of targeted therapy

article Full Text OpenAlex

近5年高被引文献
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

article Full Text OpenAlex 4025 FWCI443.6596

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

article Full Text OpenAlex 1619 FWCI179.6871

Germinal Centers

review Full Text OpenAlex 828 FWCI14.7552

Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial

article Full Text OpenAlex 804 FWCI61.4041

Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

article Full Text OpenAlex 765 FWCI81.1899

Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial

article Full Text OpenAlex 577 FWCI64.5949

Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

article Full Text OpenAlex 492 FWCI48.4343

Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study

article Full Text OpenAlex 461 FWCI53.2155

Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma

article Full Text OpenAlex 455 FWCI46.8255

A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma

article Full Text OpenAlex 406 FWCI29.6184